From the Food and Drug Administration.
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D004347:Drug Interactions; D004791:Enzyme Inhibitors; D006801:Humans; D020902:Hypericum / Q000009:adverse effects*; D015242:Ofloxacin / Q000627:therapeutic use*; D010403:Penicillin Resistance; D010946:Plants, Medicinal; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D004791:Enzyme Inhibitors; D015242:Ofloxacin